Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

About the Cover

July 2022; Volume 42,Issue 7

Reviews

  • Open Access
    Long Non-coding RNAs Sponging MicroRNAs With Efficacy in Preclinical In Vivo Models of Esophageal Squamous Cell Cancer
    ULRICH H. WEIDLE and ADAM NOPORA
    Anticancer Research July 2022, 42 (7) 3233-3249; DOI: https://doi.org/10.21873/anticanres.15813
  • Open Access
    Intradural Extramedullary Spinal Metastases from Non-neurogenic Primary Tumors: A Systematic Review
    PAOLO PALMISCIANO, ANDREW L. CHEN, MAYUR SHARMA, OTHMAN BIN-ALAMER, GIANLUCA FERINI, GIUSEPPE E. UMANA, SALAH G. AOUN and ALI S. HAIDER
    Anticancer Research July 2022, 42 (7) 3251-3259; DOI: https://doi.org/10.21873/anticanres.15814
  • Open Access
    Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations–State-of-the-Art
    EVANGELOS DIMAKAKOS, GEORGIA GOMATOU, MARIELLA CATALANO, DAN-MIRCEA OLINIC, ALEX C. SPYROPOULOS, ANNA FALANGA, ANTHONY MARAVEYAS, AARON LIEW, SAM SCHULMAN, JILL BELCH, GRIGORIOS GEROTZIAFAS, PETER MARSCHANG, BENILDE COSMI, JONAS SPAAK, KONSTANTINOS SYRIGOS and CANCER-COVID-19 THROMBOSIS COLLABORATIVE GROUP, endorsed by VAS-European Independent Foundation in Angiology/Vascular Medicine, UEMS Vascular Medicine/Angiology and European Society of Vascular Medicine, and supported by the Balkan Working Group for Prevention and Treatment of Venous Thromboembolism and Hellenic Association of Lung Cancer
    Anticancer Research July 2022, 42 (7) 3261-3274; DOI: https://doi.org/10.21873/anticanres.15815
  • Open Access
    Immunotherapy for Non-small Cell Lung Cancer: Current Agents and Potential Molecular Targets
    NELSON OW SHAM, LEI ZHAO, ZIWEN ZHU, TANNER M. ROY, HUAPING XIAO, QIAN BAI, MARK R. WAKEFIELD and YUJIANG FANG
    Anticancer Research July 2022, 42 (7) 3275-3284; DOI: https://doi.org/10.21873/anticanres.15816
  • Open Access
    Postoperative Pancreatic Fistula: Is Minimally Invasive Surgery Better than Open? A Systematic Review and Meta-analysis
    NICCOLO PETRUCCIANI, ANNA CROVETTO, FRANCESCA DE FELICE, MARCO PACE, DIEGO GIULITTI, MARCO YUSEF, GIUSEPPE NIGRI, STEFANO VALABREGA, RADWAN KASSIR, FRANCESCO D’ANGELO, TAREK DEBS, GIOVANNI RAMACCIATO and PAOLO AURELLO
    Anticancer Research July 2022, 42 (7) 3285-3298; DOI: https://doi.org/10.21873/anticanres.15817

Experimental Studies

  • Open Access
    High Expression of p62 and ALDH1A3 Is Associated With Poor Prognosis in Luminal B Breast Cancer
    AYAKA OZAKI, HITOMI MOTOMURA, SHOMA TAMORI, CHOTARO ONAGA, YUKA NAGASHIMA, MAHO KOTORI, CHIKA MATSUDA, AKARI MATSUDA, NANAKO MOCHIZUKI, TSUGUMICHI SATO, YASUSHI HARA, KEIKO SATO, YOHEI MIYAGI, YOJI NAGASHIMA, TAKEHISA HANAWA, YOHSUKE HARADA, YUYUN XIONG, KAZUNORI SASAKI, SHIGEO OHNO and KAZUNORI AKIMOTO
    Anticancer Research July 2022, 42 (7) 3299-3312; DOI: https://doi.org/10.21873/anticanres.15818
  • You have access
    Saturated Fatty Acids in Cell Membrane Lipids Induce Resistance to 5-Fluorouracil in Colorectal Cancer Cells
    TAKANORI HIRAIDE, YOSHIFUMI MORITA, MAKOTO HORIKAWA, EIJI SUGIYAMA, TOMOHITO SATO, TOMOAKI KAHYO, SATORU FURUHASHI, MAKOTO TAKEDA, HIROTOSHI KIKUCHI, YOSHIHIRO HIRAMATSU, TAKANORI SAKAGUCHI, HIROYUKI KONNO, MITSUTOSHI SETOU and HIROYA TAKEUCHI
    Anticancer Research July 2022, 42 (7) 3313-3324; DOI: https://doi.org/10.21873/anticanres.15819
  • You have access
    PI3K/Akt and Wnt/β-catenin Signaling Cross-regulate NF-κB Signaling in TNF-α-induced Human Lgr5+ Intestinal Stem Cells
    XIAOPENG ZHAO, BINBIN MA, HONGLI ZHU, JUN BAI, LIXIU LIU, XIAONING LI, JING CAI, BEIBEI WANG, LIJUN WANG, YUAN PANG, HUI ZHANG, YI YANG, NAN LI and MEI CHEN
    Anticancer Research July 2022, 42 (7) 3325-3340; DOI: https://doi.org/10.21873/anticanres.15820
  • Open Access
    Comparative Analysis of the Antitumor Immune Profiles of Paired Radiotherapy-naive and Radiotherapy-treated Cervical Cancer Tissues
    AYAKA IMAMURA, TAKAHIRO OIKE, HIRO SATO, YUYA YOSHIMOTO, KEN ANDO and TATSUYA OHNO
    Anticancer Research July 2022, 42 (7) 3341-3348; DOI: https://doi.org/10.21873/anticanres.15821
  • You have access
    The Role of Inflammation-associated microRNA-4257 as a Promoter of Malignancy in Colorectal Cancer
    SATOSHI KATAOKA, TOMOHIRO ARITA, HIROTAKA KONISHI, YUSUKE YAMAMOTO, RIE SHIBATA, TAIGA YAMAMOTO, JUN SHIBAMOTO, HIROTAKA FURUKE, KAZUYA TAKABATAKE, WATARU TAKAKI, JUN KIUCHI, HIROKI SHIMIZU, SHUHEI KOMATSU, ATSUSHI SHIOZAKI, YOSHIAKI KURIU and EIGO OTSUJI
    Anticancer Research July 2022, 42 (7) 3349-3360; DOI: https://doi.org/10.21873/anticanres.15822
  • You have access
    SOCS1 Gene Therapy for Head and Neck Cancers: An Experimental Study
    TAIHEI KAJIYAMA, SATOSHI SERADA, MINORU FUJIMOTO, TOMOHARU OHKAWARA, MASAHIRO KOMORI, MASAMITSU HYODO and TETSUJI NAKA
    Anticancer Research July 2022, 42 (7) 3361-3372; DOI: https://doi.org/10.21873/anticanres.15823
  • You have access
    Implications of PD-1, Tim-3, and TIGIT Expression for Cancer Immunity and Pancreatic Cancer Prognosis
    CHIERI NAKAYAMA, KIYONORI TANOUE, TETSUYA IDICHI, HIROKI SHIMOMURA, YOSHIAKI KITA, YUTO HOZAKA, YOSHIAKI SHINDEN, DAISUKE MATSUSHITA, AKIHIRO NAKAJO, TAKAAKI ARIGAMI, YUKO MATAKI, HIROSHI KURAHARA and TAKAO OHTSUKA
    Anticancer Research July 2022, 42 (7) 3373-3380; DOI: https://doi.org/10.21873/anticanres.15824
  • You have access
    Significant Contribution of Interleukin-18 Genotypes to Lung Cancer Risk in Taiwanese
    MENG-FENG WU, LI-HSIOU CHEN, NING-YI HSIA, YI-CHENG SHEN, TE-CHUN SHEN, ZHI-HONG WANG, YA-CHEN YANG, YUN-CHI WANG, WEN-SHIN CHANG, TE-CHUN HSIA, DA-TIAN BAU and CHIA-WEN TSAI
    Anticancer Research July 2022, 42 (7) 3381-3387; DOI: https://doi.org/10.21873/anticanres.15825
  • You have access
    Chlorogenic Acid Inhibition of Esophageal Squamous Cell Carcinoma Metastasis via EGFR/p-Akt/Snail Signaling Pathways
    YU-KUEI CHEN, NGO TRAN MY NGOC, HSI-WEN CHANG, YING-FANG SU, CHUNG-HWAN CHEN, YIH-GANG GOAN, JEFF YI-FU CHEN, CHUN-WEI TUNG and TZYH-CHYUAN HOUR
    Anticancer Research July 2022, 42 (7) 3389-3402; DOI: https://doi.org/10.21873/anticanres.15826
  • You have access
    Targeted Treatment of HPV16-positive and -negative SCC Cells With Small Molecule Tyrosine Kinase Inhibitors and Everolimus Affects MMP2 and MMP14 Expression
    LENA HUBER, RICHARD BIRK, MANUEL KNUETTEL, NICOLE ROTTER, CHRISTOPH ADERHOLD, CLAUDIA SCHERL, ANNE LAMMERT, FREDERIC JUNGBAUER and BENEDIKT KRAMER
    Anticancer Research July 2022, 42 (7) 3403-3411; DOI: https://doi.org/10.21873/anticanres.15827
  • You have access
    Valproic Acid Enhances Radiosensitization via DNA Double-strand Breaks for Boronophenylalanine-mediated Neutron Capture Therapy in Melanoma Cells
    ZIH-YIN LAI, DING-YU LI, CHU-YU HUANG, KAI-CHE TUNG, CHUNG-CHI YANG, HONG-MING LIU, FONG-IN CHOU and YUNG-JEN CHUANG
    Anticancer Research July 2022, 42 (7) 3413-3426; DOI: https://doi.org/10.21873/anticanres.15828
  • You have access
    Synergistic Benefit of Adoptive T Cells in Combination With Chemoradiotherapy Against Metastatic Prostate Cancer Cells
    YUN-CHU SHEN, HUNG-JEN SHIH, CHI-CHIEN LIN, SHENG-HSIEN HUANG, SHENG-CHUAN WU, CHI-HAO HSIAO, SHAO-CHI CHIU, DER-YANG CHO, CHIN-PAO CHANG, YUEH PAN and PING-HSIAO SHIH
    Anticancer Research July 2022, 42 (7) 3427-3434; DOI: https://doi.org/10.21873/anticanres.15829
  • You have access
    The Casein Kinase 2 Inhibitor CX-4945 Promotes Cholangiocarcinoma Cell Death Through PLK1
    DA SOL LEE, SEONMIN LEE, CHORONG KIM, DANBEE KIM, KYU-PYO KIM and CHANGHOON YOO
    Anticancer Research July 2022, 42 (7) 3435-3443; DOI: https://doi.org/10.21873/anticanres.15830
  • You have access
    Up-regulation of CPNE1 Appears to Enhance Cancer Progression in HER2-positive and Luminal A Breast Cancer Cells
    HYE YOUNG CHOI, HYO JUNG LEE, KYOUNG MI MOON, DONG KYU MOON, SECHAN LEE, HYEWON PARK, JINPYO HONG, MI JUNG PARK, DONG KYUN WOO and JAE CHEAL YOO
    Anticancer Research July 2022, 42 (7) 3445-3452; DOI: https://doi.org/10.21873/anticanres.15831
  • You have access
    Antibody-immunotoxin Conjugate Using FcBP-mediated Photoconjugation to Treat Cancer
    KWANG-HYEOK KIM, JISOO PARK, JIN-OCK KIM, HAN-JIK KO and SANG GYU PARK
    Anticancer Research July 2022, 42 (7) 3453-3461; DOI: https://doi.org/10.21873/anticanres.15832
  • You have access
    Enhanced Tumoricidal Immune Responses by Transarterial Chemotherapy Using Novel Nanocomplexes in a Rat Liver Cancer Model
    BYUNG-YOON KANG, SUNG MIN KIM, WONHEE HUR, PU REUN ROH, JI WON HAN, PIL SOO SUNG, EUNYOUNG TAK, WON JONG KIM, LONG JIN, HO JONG CHUN and SEUNG KEW YOON
    Anticancer Research July 2022, 42 (7) 3463-3473; DOI: https://doi.org/10.21873/anticanres.15833
  • You have access
    Knockdown of NUPR1 Enhances the Sensitivity of Non-small-cell Lung Cancer Cells to Metformin by AKT Inhibition
    YU JIN KIM, SUNG-EUN HONG, SE-KYEONG JANG, KI SOO PARK, CHUN-HO KIM, IN-CHUL PARK and HYEON-OK JIN
    Anticancer Research July 2022, 42 (7) 3475-3481; DOI: https://doi.org/10.21873/anticanres.15834
  • You have access
    Biomarker Profiling Revealed Carcinoembryonic Antigen as a Target of Artesunate in a Ductal Breast Cancer Patient
    MOHAMED E.M. SAEED, ASSIA I. DRIF and THOMAS EFFERTH
    Anticancer Research July 2022, 42 (7) 3483-3494; DOI: https://doi.org/10.21873/anticanres.15835
  • You have access
    Hydroxychloroquine Promotes Bcl-xL Inhibition-induced Apoptosis in BxPC-3 Human Pancreatic Cancer Cells
    MOHAMMAD MAHBUBUL HOQUE, YUICHI IIDA, HITOSHI KOTANI, IRNA DIYANA KARTIKA and MAMORU HARADA
    Anticancer Research July 2022, 42 (7) 3495-3506; DOI: https://doi.org/10.21873/anticanres.15836
  • You have access
    Comparative Proteomic Profiling of Cisplatin-resistant Nasopharyngeal Carcinoma Cell Lines: Novel Biomarkers for Improving Chemotherapy of NPC
    PARISA PRATHAPHAN, ONRAPAK REAMTONG, UTAPIN NGAOKRAJANG, TAVAN JANVILISRI, NAPACHANOK MONGKOLDHUMRONGKUL SWAINSON and PICHAMON KIATWUTHINON
    Anticancer Research July 2022, 42 (7) 3507-3522; DOI: https://doi.org/10.21873/anticanres.15837

Clinical Studies

  • You have access
    Dynamic Contrast-enhanced CT to Evaluate Early Response in Neuroendocrine Liver Metastases Treated With Everolimus and Radiation
    JOHN MONTE HUDSON, SIMRON SINGH, LAURENT MILOT, CHIRAG PATEL, COLLEEN BAILEY, VICTOR RODRIGUEZ-FREIXINOS, DAVID CHAN, JULIE HALLET, CALVIN LAW and STEN MYREHAUG
    Anticancer Research July 2022, 42 (7) 3523-3527; DOI: https://doi.org/10.21873/anticanres.15838
  • Open Access
    Long-term Outcomes of Radiation Therapy for Prostate Cancer in Elderly Patients Aged ≥75 Years
    ERINA NAKANISHI, TAKERO HIRATA, KEISUKE TAMARI, FUMIAKI ISOHASHI, OSAMU SUZUKI, KAZUHIKO HAYASHI, YUJI SEO, YUICHI AKINO, YASUTOSHI FUMIMOTO, KOJI HATANO, ATSUNARI KAWASHIMA, MOTOHIDE UEMURA, SHINICHI SHIMIZU, NORIO NONOMURA and KAZUHIKO OGAWA
    Anticancer Research July 2022, 42 (7) 3529-3536; DOI: https://doi.org/10.21873/anticanres.15839
  • Open Access
    Characterization of the Immunological Status of Hypermutated Solid Tumors in the Cancer Genome Analysis Project HOPE
    YASUTO AKIYAMA, RYOTA KONDOU, AKIRA IIZUKA, HARUO MIYATA, CHIE MAEDA, AKARI KANEMATSU, TADASHI ASHIZAWA, TAKESHI NAGASHIMA, KENICHI URAKAMI, YUJI SHIMODA, KEIICHI OHSHIMA, AKIO SHIOMI, YASUHISA OHDE, MASANORI TERASHIMA, KATSUHIKO UESAKA, YASUYUKI HIRASHIMA, YOSHIO KIYOHARA, HIROHISA KATAGIRI, TAKASHI SUGINO, AKIFUMI NOTSU, KEITA MORI, MITSURU TAKAHASHI, HIROTSUGU KENMOTSU and KEN YAMAGUCHI
    Anticancer Research July 2022, 42 (7) 3537-3549; DOI: https://doi.org/10.21873/anticanres.15840
  • Open Access
    Impact of Dose-Volume Parameters of Parotid Glands on Xerostomia in Patients Irradiated for Head-and-Neck Cancer
    DIRK RADES, BRITTA WARWAS, FLORIAN CREMERS, KARSTEN GERULL, CHRISTIAN IDEL, KARL L. BRUCHHAGE, SAMER G. HAKIM and STEVEN E. SCHILD
    Anticancer Research July 2022, 42 (7) 3551-3556; DOI: https://doi.org/10.21873/anticanres.15841
  • Open Access
    Site-specific Performance of ColonView (CV) Fecal Immunochemical Test (FIT) With Differences Between Proximal and Distal Colorectal Adenoma
    MAARET ESKELINEN, JANNICA MEKLIN, DENISE PEIXOTO GUIMARAES, TUOMAS SELANDER, TAPANI TIUSANEN, KARI SYRJÄNEN and MATTI ESKELINEN
    Anticancer Research July 2022, 42 (7) 3557-3567; DOI: https://doi.org/10.21873/anticanres.15842
  • You have access
    Can We Predict a Higher Risk of Urothelial Bladder Cancer With a Simple Blood Test?
    BRENDAN WALLACE, SNIR DEKALO, MHRAN KABHA, ISHAI MINTZ, HAIM MATZKIN and NICOLA J. MABJEESH
    Anticancer Research July 2022, 42 (7) 3569-3573; DOI: https://doi.org/10.21873/anticanres.15843
  • You have access
    Evaluation of Durvalumab-induced Lung Toxicity Using a Spontaneous Reporting Database
    JUNYA SATO, KANA NAKANO, TADASHI SHIMIZU and MAYAKO UCHIDA
    Anticancer Research July 2022, 42 (7) 3575-3582; DOI: https://doi.org/10.21873/anticanres.15844
  • You have access
    Nestin as a Prognostic Biomarker in High-grade Epithelial Ovarian Cancer Treated by Neoadjuvant Chemotherapy
    HUGO VEYSSIÈRE, GHASSAN ALDARAZI, IOANA MOLNAR, XAVIER DURANDO and NINA RADOSEVIC-ROBIN
    Anticancer Research July 2022, 42 (7) 3583-3594; DOI: https://doi.org/10.21873/anticanres.15845
  • You have access
    Polyserositis as a Unique Presentation of Isolated Myeloid Sarcoma: A Case Report
    PALASH ASAWA, URWAT VUSQA, KIRTIVARDHAN VASHISTHA, MIAN TANVEER UD DIN, RAHUL KARNA, FEIFAN CHEN, NINA DUTTON, YAZAN SAMHOURI and SALMAN FAZAL
    Anticancer Research July 2022, 42 (7) 3595-3599; DOI: https://doi.org/10.21873/anticanres.15846
  • You have access
    Synchronous Penile Squamous Cell Carcinoma, Bladder Urothelial Carcinoma and Prostate Adenocarcinoma Diagnosed in One Procedure
    FRANK DENG, MAX X. KONG and JINPING LAI
    Anticancer Research July 2022, 42 (7) 3601-3605; DOI: https://doi.org/10.21873/anticanres.15847
  • You have access
    Letermovir Prophylaxis for Cytomegalovirus Infection in Children After Hematopoietic Cell Transplantation
    MONIKA RICHERT-PRZYGONSKA, KAMILA JAREMEK, ROBERT DEBSKI, JOANNA KONIECZEK, MONIKA LECKA, MAGDALENA DZIEDZIC, TOMASZ BOGIEL, JAN STYCZYNSKI and KRZYSZTOF CZYZEWSKI
    Anticancer Research July 2022, 42 (7) 3607-3612; DOI: https://doi.org/10.21873/anticanres.15848
  • You have access
    Clinical Benefit of Polypectomy With Cutting Current for Colorectal Polyps: A Randomized Controlled Trial
    RYOTA KOYANAGI, MICHITAKA HONDA, HIDETAKA KAWAMURA, KOICHI HAMADA, YOSHINORI HORIKAWA, YOSHIKI SHIWA, KAE TECHIGAWARA, TAKAYUKI NAGAHASHI, TEPPEI MIYAKAWA and SHINICHI KONNO
    Anticancer Research July 2022, 42 (7) 3613-3619; DOI: https://doi.org/10.21873/anticanres.15849
  • You have access
    Standardized and Feasible Laparoscopic Approach for Tumors Located in the Caudate Lobe
    YUICHI NAKASEKO, KENEI FURUKAWA, KOICHIRO HARUKI, SHINJI ONDA, JUNGO YASUDA, YOSHIHIRO SHIRAI, NORIMITSU OKUI, KEIGO NAKASHIMA, YUTAKA SUZUKI and TORU IKEGAMI
    Anticancer Research July 2022, 42 (7) 3621-3625; DOI: https://doi.org/10.21873/anticanres.15850
  • You have access
    Impact of Histological Variants on Clinical Responses to Pembrolizumab in Patients With Metastatic Urothelial Cancer
    SATOSHI INOUE, NAOTO SASSA, HIDEJI KAWANISHI, YURI YUGUCHI, TOMOHIDE SUZUKI, JUN NAGAYAMA, HIROTAKA MATSUI, YUDAI MIYATA, YUYA SOEDA, KOSUKE TOCHIGI, YUSHI YAMAUCHI, MOTOHIRO MAEDA, IKUO KOBAYASHI, RYOHEI HATTORI, YOSHIHISA MATSUKAWA and MASASHI KATO
    Anticancer Research July 2022, 42 (7) 3627-3636; DOI: https://doi.org/10.21873/anticanres.15851
  • You have access
    Impact of Amino Acids Nutrition Following Gastrectomy in Gastric Cancer Patients
    SATORU KIKUCHI, NOBUO TAKATA, SHINJI KURODA, HIBIKI UMEDA, SHUNSUKE TANABE, NAOAKI MAEDA, KOSEI TAKAGI, KAZUHIRO NOMA, YUKO HASEGAWA, KUMIKO NAWACHI, SHUNSUKE KAGAWA, YUZO UMEDA, KENICHI SHIKATA and TOSHIYOSHI FUJIWARA
    Anticancer Research July 2022, 42 (7) 3637-3643; DOI: https://doi.org/10.21873/anticanres.15852
  • You have access
    Postoperative Nutrition Status of Patients With Esophago-gastric Junction Cancer With Gastric Tube or Esophago-gastric Reconstruction
    KAZUYA TAKABATAKE, HIROTAKA KONISHI, TAKESHI KUBOTA, ATSUSHI SHIOZAKI, HITOSHI FUJIWARA, TAKUMA OHASHI, TOMOHIRO ARITA, HIROKI SHIMIZU, YUSUKE YAMAMOTO, RYO MORIMURA, HISASHI IKOMA, YOSHIAKI KURIU, KAZUMA OKAMOTO and EIGO OTSUJI
    Anticancer Research July 2022, 42 (7) 3645-3652; DOI: https://doi.org/10.21873/anticanres.15853
  • You have access
    Real-world Experience With Pembrolizumab for Advanced-stage Head and Neck Cancer Patients: A Retrospective, Multicenter Study
    TAKAFUMI NAKANO, RYUJI YASUMATSU, KAZUKI HASHIMOTO, RYOSUKE KUGA, TAKAHIRO HONGO, HIDETAKA YAMAMOTO, MIOKO MATSUO, TAKAHIRO WAKASAKI, RINA JIROMARU, TOMOMI MANAKO, SATOSHI TOH, MUNEYUKI MASUDA, MORIYASU YAMAUCHI, YUICHIRO KURATOMI, MASAHIKO TAURA, TORANOSHIN TAKEUCHI and TAKASHI NAKAGAWA
    Anticancer Research July 2022, 42 (7) 3653-3664; DOI: https://doi.org/10.21873/anticanres.15854
  • You have access
    Impact of Macroscopic Tumour Consistency and EPIC in Low-grade Appendiceal Neoplasms With Pseudomyxoma Peritonei
    ERNEST CHENG, RAPHAEL SHAMAVONIAN, JASMINE MUI, JOSH KARPES, KERRY CHEN, NIMA AHMADI and DAVID L. MORRIS
    Anticancer Research July 2022, 42 (7) 3665-3673; DOI: https://doi.org/10.21873/anticanres.15855
  • You have access
    Independent Validation of a Risk Stratification Model Predicting Survival in Patients With Metastatic Hormone-sensitive Prostate Cancer
    CARSTEN NIEDER and LUKA STANISAVLJEVIC
    Anticancer Research July 2022, 42 (7) 3675-3679; DOI: https://doi.org/10.21873/anticanres.15856
  • You have access
    Rare Histologies and Infrequent Indications for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
    ALAEDIN RAJHA, POMPILIU PISO, LASZLO HALMY, IVAN PANCZEL, DAN-SEBASTIAN NEDELCUT, ZOLTAN HEROLD, ATTILA MARCELL SZASZ and MIKLOS ACS
    Anticancer Research July 2022, 42 (7) 3681-3692; DOI: https://doi.org/10.21873/anticanres.15857
  • You have access
    Risk Factor Analysis for the Occurrence of Severe Adverse Effects in Eribulin Treatment
    YOSHITAKA SAITO, YOH TAKEKUMA, TAKASHI TAKESHITA, TAKURO NOGUCHI, SATOSHI TAKEUCHI, YASUSHI SHIMIZU, ICHIRO KINOSHITA, HIROTOSHI DOSAKA-AKITA and MITSURU SUGAWARA
    Anticancer Research July 2022, 42 (7) 3693-3700; DOI: https://doi.org/10.21873/anticanres.15858
  • Open Access
    Clinical Outcomes of Scanning Carbon-ion Radiotherapy for Soft Tissue Sarcoma of the Extremities
    YOSUKE TAKAKUSAGI, ITSUKO SERIZAWA, HIROAKI KOGE, KIO KANO, SATOSHI SHIMA, KEISUKE TSUCHIDA, NOBUTAKA MIZOGUCHI, DAISAKU YOSHIDA, HIROYUKI KATOH, TORU HIRUMA and TADASHI KAMADA
    Anticancer Research July 2022, 42 (7) 3701-3706; DOI: https://doi.org/10.21873/anticanres.15859
  • You have access
    Highly Aggressive Surgery Benefits in Patients With Advanced Ovarian Cancer
    SHINICHI TATE, KYOKO NISHIKIMI, AYUMU MATSUOKA, SATOYO OTSUKA and MAKIO SHOZU
    Anticancer Research July 2022, 42 (7) 3707-3716; DOI: https://doi.org/10.21873/anticanres.15860
  • You have access
    Relationship Between Leukotriene Receptor Antagonists on Cancer Development in Patients With Bronchial Asthma: A Retrospective Analysis
    AYAKO MAEDA-MINAMI, MAIKO HOSOKAWA, YUMI ISHIKURA, ATSUTO ONODA, YOHEI KAWANO, KENICHI NEGISHI, SHUJI SHIMADA, TOMOMI IHARA, MASAO SUGAMATA, KEN TAKEDA and YASUNARI MANO
    Anticancer Research July 2022, 42 (7) 3717-3724; DOI: https://doi.org/10.21873/anticanres.15861
  • You have access
    Strategy Treatment of cT4b Esophageal Squamous Cell Carcinoma Using Docetaxel, Cisplatin, and 5-Fluorouracil
    MASANOBU NAKAJIMA, HIROTO MUROI, MAIKO KIKUCHI, TSUKASA KUBO, SHUHEI TAKISE, KEISUKE IHARA, MASATOSHI NAKAGAWA, SHINJI MORITA, TAKATOSHI NAKAMURA, SATORU YAMAGUCHI and KAZUYUKI KOJIMA
    Anticancer Research July 2022, 42 (7) 3725-3733; DOI: https://doi.org/10.21873/anticanres.15862
  • You have access
    Impact of Tumor Progression on Survival During Neoadjuvant Chemotherapy in Breast Cancer: A Cohort Study
    KAZUKI NOZAWA, DAIKI TAKATSUKA, YUKA ENDO, NANAE HORISAWA, YURI OZAKI, AYUMI KATAOKA, HARURU KOTANI, AKIYO YOSHIMURA, MASAYA HATTORI, MASATAKA SAWAKI and HIROJI IWATA
    Anticancer Research July 2022, 42 (7) 3735-3742; DOI: https://doi.org/10.21873/anticanres.15863
  • You have access
    Impact of Older Age and Medico-social Factors on the Decision to Offer Adjuvant Chemotherapy to Patients With Breast Cancer
    KUMI NIGUMA, KANAKO MAMISHIN, YOICHI NAITO, SHOGO NOMURA, MASASHI WAKABAYASHI, SHOTA KUSUHARA, CHIKAKO FUNASAKA, TAKEHIRO NAKAO, YOKO FUKASAWA, CHIHIRO KONDOH, KENICHI HARANO, TAKAHIRO KOGAWA, NOBUAKI MATSUBARA, AKO HOSONO, TATSUYA ONISHI, TOSHIKATSU KAWASAKI and TORU MUKOHARA
    Anticancer Research July 2022, 42 (7) 3743-3751; DOI: https://doi.org/10.21873/anticanres.15864
  • You have access
    Influence of Dose Reduction of Prophylactic Dexamethasone on Chemotherapy-induced Nausea and Anorexia in Patients Under 55 Years Old Treated With Anthracycline-containing Regimens
    YOSHITAKA SAITO, YOH TAKEKUMA, TAKASHI TAKESHITA and MITSURU SUGAWARA
    Anticancer Research July 2022, 42 (7) 3753-3758; DOI: https://doi.org/10.21873/anticanres.15865
  • You have access
    The Geriatric Nutritional Risk Index as a Prognosis Predictor in Patients With Rectal Cancer Receiving Neoadjuvant Chemotherapy
    SOICHIRO MINAMI, NORIKATSU MIYOSHI, SHIKI FUJINO, SHINYA KATO, YUKI SEKIDO, TSUYOSHI HATA, TAKAYUKI OGINO, HIDEKAZU TAKAHASHI, MAMORU UEMURA, HIROFUMI YAMAMOTO, YUICHIRO DOKI and HIDETOSHI EGUCHI
    Anticancer Research July 2022, 42 (7) 3759-3766; DOI: https://doi.org/10.21873/anticanres.15866
Back to top
PreviousNext

In this issue

Anticancer Research: 42 (7)
Anticancer Research
Vol. 42, Issue 7
July 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations–State-of-the-Art
  • High Expression of p62 and ALDH1A3 Is Associated With Poor Prognosis in Luminal B Breast Cancer
  • Long Non-coding RNAs Sponging MicroRNAs With Efficacy in Preclinical In Vivo Models of Esophageal Squamous Cell Cancer
  • Intradural Extramedullary Spinal Metastases from Non-neurogenic Primary Tumors: A Systematic Review
  • Immunotherapy for Non-small Cell Lung Cancer: Current Agents and Potential Molecular Targets
Sign up for alerts

Jump to

  • Reviews
  • Experimental Studies
  • Clinical Studies
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire